-
LRRK2 Drug Trial Shares Promising Results, Company to Begin Second Study
December 21, 2017
… positive results from its first-in-human LRRK2 inhibitor clinical trial. The experimental treatment is safe, and … can do). Denali also shared it is testing a second compound in a separate Phase I trial in control volunteers. … earlier report on Denali's initial public offering. In a press release, the company announced its first trial showed …
-
“No Picnic but Worth Doing”: Deep Brain Stimulation
January 24, 2014
… a rich life with his wife, Janet Froelich. Three years into his Parkinson’s disease, after a diagnosis in the … He watched Internet videos of the procedure and spoke to nearly a dozen people who had undergone the surgery. “They … freezing,” he says. The Michael J. Fox Foundation supports research to improve on the current standard DBS procedure, …
-
Studying the Production of Mitochondria to Find New Therapeutic Targets for Parkinson's Disease
… it. Hypothesis: Our study will provide additional insight into the production of faulty mitochondria and will give us … using drugs so cells produce better mitochondria. Impact on Diagnosis/Treatment of Parkinson's disease: In this study, … in the diagnosis of PD. Next Steps for Development: If our research project is successful, we will look for drugs to …
-
Probabilistic modelling of gait for robust passive monitoring in daily life
November 16, 2020
… monitoring in daily life may provide valuable insights into a person's health throughout the day. Wearable sensor … predictions that can be used to support clinical diagnosis and treatment. In this work we develop a … probabilistic framework designed to segment signals into differing gait and non-gait patterns. We evaluate the …
-
The Michael J. Fox Foundation Publishes New Resource, “If I Knew Then What I Know Now: Guide for People Newly Diagnosed with Parkinson’s,” Authored by Patients to Provide Insights and Wisdom on Parkinson’s Disease
May 19, 2020
… engagement, The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today launches an educational resource, “If … Markers Initiative , a landmark clinical study including nearly 1,400 participants — focused on identifying and … research funders; increases the flow of participants into Parkinson's disease clinical trials with its online …
-
Phase III Trial to Slow Parkinson's Now Recruiting around The United States
June 27, 2016
… A compound that researchers believe may lower the risk of Parkinson's … more slowly. The compound inosine is converted by the body into urate. A Phase II trial, funded by The Michael J. Fox … largest single grant at that time. MJFF also supported early pre-clinical work investigating the mechanism of urate …